A Failure Pattern Analyses in NSCLC Patients Received Immuno-Radiotherapy and a Dosimetric Feasibility Study of a Three-...
Introduction Stage III non-small cell lung cancer (NSCLC) represents a heterogeneous disease with historically poor outcomes, necessitating multimodal therapeutic approaches. The current standard of care—concurrent chemoradiotherapy (CCRT) followed by …